Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1986 | 06-1986 | 09-1985 | 06-1985 | 09-1984 | |
| Sales | 560 | 0 | 0 | 0 | 0 |
| Cost of Goods | 371 | N/A | N/A | N/A | N/A |
| Gross Profit | 189 | N/A | N/A | N/A | N/A |
| Operating Expenses | 1,996 | 0 | 0 | 0 | 0 |
| Operating Income | -1,435 | N/A | N/A | N/A | N/A |
| Interest Expense | 71 | 0 | 0 | 0 | 0 |
| Other Income | 253 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -1,253 | 0 | 0 | 0 | 0 |
| Income Tax | 27 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -1,280 | N/A | N/A | N/A | N/A |
| Net Income | $-1,280 | $N/A | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -0.27 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -0.27 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.27 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -0.27 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,435 | $N/A | $N/A | $N/A | $N/A |